Company Filing History:
1 out of 20 
1 out of 15 Years Active: 2011-2017
Title: The Innovative Journey of Eric Thorin: A Trailblazer in Scientific Patents
Introduction: Eric Thorin, a distinguished inventor based in Montreal, Canada, has made significant contributions to the field of medical research through his innovative inventions. With a total of two patents to his name, Thorin stands out as a key figure in the realm of biotechnology and healthcare.
Latest Patents: Eric Thorin's latest patents highlight his expertise in addressing vital health challenges. The first patent is titled "Composition Comprising Inhibitors of IRS-1 and of VEGF." This invention pertains to a composition or kit designed to include an inhibitor of IRS-1 alongside an inhibitor of the VEGF pathway. Its application is particularly pertinent for treating various angiogenic diseases. The second patent represents a substantial advancement in diagnostic methods: "Angiopoietin-like 2 as a Biomarker of Vascular Endothelial Cell Abnormal Function and Senescence." This method entails assessing the physiological state of a mammal by measuring the expression of angiopoietin-like 2 in a biological sample and comparing it against predetermined normal expression levels, thus providing insights into abnormal physiological states.
Career Highlights: Throughout his career, Eric Thorin has worked with notable organizations that enhance his profile as an inventor. Among these are Gene Signal International and the Institut De Cardiologie De Montreal, where he has applied his research and innovation to improve medical outcomes.
Collaborations: Collaboration has been key to Thorin's success as an inventor. He has worked alongside esteemed colleagues, including Salman Al-Mahmood and Sylvie Colin, sharing knowledge and expertise that has propelled his research endeavors forward.
Conclusion: Eric Thorin's contributions to the field of biomedical patents are notable and impactful. His innovative work reflects a commitment to advancing medical science and improving patient care. As a leading innovator in his field, Thorin continues to pave the way for future developments in medical treatment and diagnostics.